Does weight return after stopping Wegovy — and what can you do about it?

What the trial data actually showed when people stopped

The STEP 1 withdrawal extension is the clearest evidence we have. In that study, participants who had lost around 15% of their body weight on semaglutide 2.4mg over 68 weeks were then followed for a further year without the medicine. By the end of that year, the majority had regained roughly two-thirds of the weight they had lost, while the health improvements that had come with weight loss (blood pressure, blood sugar, cholesterol) largely reversed in parallel. The researchers published their findings in the STEP 1 trial paper in the New England Journal of Medicine, and the pattern was consistent enough that the authors concluded weight management with semaglutide requires ongoing treatment in most people.

That finding surprises some people. There is a persistent idea that a course of treatment will reset your appetite permanently. It does not. Semaglutide works by mimicking a gut hormone your body already produces; when you stop taking it, those mimicked signals disappear. Your appetite gradually returns to where it was before, and so does your weight, unless other things have changed.

What does shift during treatment is the opportunity to build habits, different eating patterns, more movement, a clearer sense of which foods keep you full. Those habits can slow regain even after stopping, though they rarely stop it entirely on their own.

The factors that shape how much weight comes back

Not everyone regains at the same rate. Several things influence the picture. How long you were on treatment matters: people who took the medicine for longer and reached a stable maintenance dose tended to have more deeply embedded lifestyle changes. How much weight you lost also plays a role, a larger loss gives more runway before you are back at your starting point. And the lifestyle support you had alongside treatment makes a real difference. NHS England's guidance on weight management injections is explicit that medicines work best alongside dietary and activity changes, not instead of them; that is true during treatment and matters even more afterwards.

The dose you were on when you stopped can also affect the trajectory. Stopping abruptly from a higher dose is generally harder on the body's adjustment than a gradual planned reduction, though any change should be discussed with your prescriber first, not decided unilaterally.

It is also worth knowing that for some people, weight management is a long-term medical undertaking in the same way that blood pressure management is. NICE's recommendation for semaglutide (Wegovy) includes a note that the medicine is licensed for ongoing use, and the NICE appraisal TA875 sets a two-year limit specifically for NHS provision within specialist services, private clinical use is governed by the licensed indication and the prescriber's ongoing assessment. The two-year figure is an NHS commissioning rule, not a clinical ceiling that applies universally.

Planning a stop, what makes it go better

If you and your prescriber agree that stopping is the right move, planning the exit matters. A few things consistently make the transition easier. First, don't stop on a day when everything else is in flux, sustained routines around meals and movement give you a better foundation. Second, keep the protein-adequate, fibre-rich eating pattern you may have settled into during treatment; it is one of the few things that genuinely slows the return of appetite.

Third, be honest with yourself and your clinical team about what you are experiencing. Regain that starts quickly is often a signal that stopping was premature, or that a lower maintenance dose rather than a full stop was the better plan. If you are thinking through the timing and method, our guide to stopping Wegovy covers what to consider before you make any change, and the practical picture in the weeks after stopping is worth reading before you make any change.

One cost-related note: the financial side of long-term treatment is a real consideration for many people. You can find an honest overview of what treatment involves on our treatment and pricing page, which sets out exactly what a single transparent price covers (consultation, prescription, delivery and ongoing clinical support) with no subscription and no auto-renewal.

What this means for your decision right now

The question of whether to continue, pause or stop Wegovy is genuinely personal, and there is no universal right answer. Some people reach their goal, feel confident in their habits, and accept that some regain is likely, a considered trade-off. Others find that the biology of regain is strong enough that continuing treatment at a lower maintenance dose makes more sense than stopping entirely. A smaller group have medical reasons to stop: a planned pregnancy, a surgical procedure, or a side effect that outweighs the benefit.

What is consistent across all of those situations is that the decision should involve a prescriber who knows your case. Stopping a prescription medicine without a clinical conversation risks a faster, steeper regain and no plan to manage it. If you are weighing this up, understanding the weight-regain pattern in more detail is a reasonable starting point, as is speaking to our prescribers about what ongoing or alternative treatment might look like. You can also read more about how Wegovy works as a treatment before making any decision. Check your eligibility and start a free consultation at any point, a real clinician reads every response the same day.